These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4620372)

  • 21. [Evaluation of 19583RP (ketoprofen) in the treatment of chronic rheumatoid arthritis].
    Shiokawa Y; Abe T; Onoda T
    Ryumachi; 1974 Oct; 14(3):279-86. PubMed ID: 4615379
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharmacodynamics and adverse effects of modern nonsteroid anti-inflammatory agents].
    Guobis G; Iushenaite Ia
    Ter Arkh; 1981; 53(7):142-51. PubMed ID: 6457407
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical study of a new anthranilic acid derivative: flufenamic acid].
    Colombo B; Chériè Lignière G; Mantellini P
    Reumatismo; 1969; 21(3):114-21. PubMed ID: 4929605
    [No Abstract]   [Full Text] [Related]  

  • 24. Namoxyrate in rheumatic disorders.
    Denko CW; DeFelice EA; Shaffer J
    Curr Ther Res Clin Exp; 1965 Dec; 7(12):749-58. PubMed ID: 4954445
    [No Abstract]   [Full Text] [Related]  

  • 25. [Results of an open study and a controlled comparative study of feprazone and naproxen in patients with rheumatoid arthritis or osteoarthrosis (author's transl)].
    Crone M; Geimer R
    Wien Med Wochenschr; 1981 Dec; 131(23-24):597-601. PubMed ID: 7039147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Long-term comparative study of fenbufen and aspirin in patients with rheumatoid arthritis].
    Soldati R; Sorbilli G; Di Benedetto P
    Clin Ter; 1980 Feb; 92(4):417-32. PubMed ID: 6969642
    [No Abstract]   [Full Text] [Related]  

  • 27. A six-month parallel group comparison of fenbufen and naproxen in the treatment of rheumatoid arthritis.
    Khan FM
    Clin Ther; 1983; 5(5):483-7. PubMed ID: 6352034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical observations with a preparation with a base of 4-isobutylphenyl-2-propionate of lysine in degenerative rheumatic diseases].
    Zucchi A; Marchese C; Tassini T; Soldati R
    Clin Ter; 1979 Dec; 91(5):467-83. PubMed ID: 120797
    [No Abstract]   [Full Text] [Related]  

  • 29. [Evaluation of the efficacy and tolerance of a new non-steroidal anti-inflammatory agent, isoxicam].
    Marcolongo R; Giordano N; Fioravanti A; Frati E; Mariani AM; Casini A
    Clin Ter; 1984 Dec; 111(6):513-9. PubMed ID: 6525811
    [No Abstract]   [Full Text] [Related]  

  • 30. Double-blind clinical trial of protacine versus oxyphenbutazone in rheumatic disorders.
    Loizzi P; Pipitone V; Bignamini AA
    Pharmatherapeutica; 1980; 2(5):285-92. PubMed ID: 7001487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A new anti-inflammatory agent: calcium bucloxate in pediatrics].
    Debray H; Galland A
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1440-2. PubMed ID: 4548650
    [No Abstract]   [Full Text] [Related]  

  • 32. Pro-drugs of non-steroidal anti-inflammatory agents.
    Mizushima Y
    Eur J Rheumatol Inflamm; 1983; 6(2):141-2. PubMed ID: 6370701
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical evaluation of a new anti-inflammatory agent in the field of otorhinolaryngology].
    Roux O
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1975 Sep; 24(7):545-7. PubMed ID: 129512
    [No Abstract]   [Full Text] [Related]  

  • 34. [Esfar in an ENT department].
    Traissac L; Pasquet J
    Rev Laryngol Otol Rhinol (Bord); 1976; 97(3-4):177-9. PubMed ID: 1034331
    [No Abstract]   [Full Text] [Related]  

  • 35. A study of repeated administration of fenbufen in patients with chronic rheumatic disorders and renal impairment.
    Armstrong R; Bradbrook I; Gibson TJ; Morrison P; Rogers HJ; Spector RG
    Eur J Rheumatol Inflamm; 1982; 5(3):294-300. PubMed ID: 7084290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Statistical evaluation of the therapeutic effect of a new antirheumatic drug, mefenamic acid, on rheumatoid arthritis].
    Colombo B; Mantellini P; Caruso I
    Reumatismo; 1967; 19(5):317-27. PubMed ID: 5617956
    [No Abstract]   [Full Text] [Related]  

  • 37. [A field study: piroxicam in arthrosis and soft tissue rheumatism. Results of a multicenter study].
    Knüsel O; Hinz G
    Schweiz Rundsch Med Prax; 1983 Sep; 72(37):1189-94. PubMed ID: 6356121
    [No Abstract]   [Full Text] [Related]  

  • 38. [Long-term treatment of inflammatory and degenerative joint diseases with piroxicam - a field trial].
    Eberl R
    Wien Med Wochenschr; 1980; 130 Spec No():36-42. PubMed ID: 7006221
    [No Abstract]   [Full Text] [Related]  

  • 39. OMERACT and the clinical evaluation of new therapeutic agents: a bird's eye view. OMERACT Committee.
    Strand V
    J Rheumatol; 1993 Mar; 20(3):588-9. PubMed ID: 8478881
    [No Abstract]   [Full Text] [Related]  

  • 40. [Methods for evaluating non-steroidal anti-inflammatory agents in rheumatoid polyarthritis].
    Vignon E; Vignon G
    Sem Hop; 1983 Dec; 59(46):3180-2. PubMed ID: 6318335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.